Clinton to Propose Increase for NIH & NCI Significantly Higher Than In Previous Years
In Brief: Gift to Jefferson Funds Capizzi Professorship; Abrams Named Special Assistant to DDES
FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld
Medicare Program: HCFA Expands Coverage Of Cancer Screening Methods
1998 Cancer Meetings Listed Through Oct.
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival









